Analyst Ratings for Intensity Therapeutics, Inc. (INTS)
INTS Rating Summary
INTS Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.50 (-68.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$2.50 (-68.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2025 | Brookline Capital Markets | Kumaraguru Raja | Upgrade | Buy (Hold) |
3.00 (N/A) |
0.27 (7.95) |
2844.44% | Details |
| 7/28/2025 | ThinkEquity | N/A | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.33 (7.95) |
2309.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
